Anti-Tac(Fv)-PE38 (LMB-2)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-Tac(Fv)-PE38 (LMB-2), covering 2012-10-24 to 2012-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia [Phase 2]